Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: MarketLine | PRODUCT CODE: 1125539

Cover Image

PUBLISHER: MarketLine | PRODUCT CODE: 1125539

Top 5 Emerging Countries Generics Market Summary, Competitive Analysis and Forecast, 2017-2026

PUBLISHED:
PAGES: 144 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 995
PDF (Site License)
USD 1492
PDF (Enterprise License)
USD 1990

Add to Cart

Summary

The Emerging 5 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

These countries contributed $112,996.1 million to the global generics industry in 2021, with a compound annual growth rate (CAGR) of 7.3% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $142,172.4 million in 2026, with a CAGR of 4.7% over the 2021-26 period.

Within the generics industry, China is the leading country among the top 5 emerging nations, with market revenues of $85,327.0 million in 2021. This was followed by India and Mexico with a value of $17,283.5 and $6,849.9 million, respectively.

China is expected to lead the generics industry in the top five emerging nations, with a value of $102,263.8 million in 2026, followed by India and Mexico with expected values of $26,692.2 and $8,504.7 million, respectively.

Scope

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five generics market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five generics market
  • Leading company profiles reveal details of key generics market players' emerging five operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the emerging five generics market with five year forecasts by both value and volume
  • Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country

Reasons to Buy

  • What was the size of the emerging five generics market by value in 2021?
  • What will be the size of the emerging five generics market in 2026?
  • What factors are affecting the strength of competition in the emerging five generics market?
  • How has the market performed over the last five years?
  • How large is the emerging five generics market in relation to its regional counterparts?
Product Code: MLIG220030-05

Table of Contents

1 Introduction

  • 1.1. What is this report about?
  • 1.2. Who is the target reader?
  • 1.3. How to use this report
  • 1.4. Definitions

2 Top 5 Emerging Countries Generics

  • 2.1. Industry Outlook

3 Generics in South Africa

  • 3.1. Market Overview
  • 3.2. Market Data
  • 3.3. Market Segmentation
  • 3.4. Market outlook
  • 3.5. Five forces analysis

4 Macroeconomic Indicators

  • 4.1. Country data

5 Generics in Brazil

  • 5.1. Market Overview
  • 5.2. Market Data
  • 5.3. Market Segmentation
  • 5.4. Market outlook
  • 5.5. Five forces analysis

6 Macroeconomic Indicators

  • 6.1. Country data

7 Generics in China

  • 7.1. Market Overview
  • 7.2. Market Data
  • 7.3. Market Segmentation
  • 7.4. Market outlook
  • 7.5. Five forces analysis

8 Macroeconomic Indicators

  • 8.1. Country data

9 Generics in India

  • 9.1. Market Overview
  • 9.2. Market Data
  • 9.3. Market Segmentation
  • 9.4. Market outlook
  • 9.5. Five forces analysis

10 Macroeconomic Indicators

  • 10.1. Country data

11 Generics in Mexico

  • 11.1. Market Overview
  • 11.2. Market Data
  • 11.3. Market Segmentation
  • 11.4. Market outlook
  • 11.5. Five forces analysis

12 Macroeconomic Indicators

  • 12.1. Country data

13 Company Profiles

14 Appendix

  • 14.1. Methodology
  • 14.2. About MarketLine
Product Code: MLIG220030-05

List of Tables

  • Table 1: Top 5 emerging countries generics industry, revenue ($m), 2017-26
  • Table 2: Top 5 emerging countries generics industry, revenue ($m), 2017-21
  • Table 3: Top 5 emerging countries generics industry forecast, revenue ($m), 2021-26
  • Table 4: South Africa generics market value: $ million, 2016-21
  • Table 5: South Africa generics market volume: %, 2016-21
  • Table 6: South Africa generics market geography segmentation: $ million, 2021
  • Table 7: South Africa generics market value forecast: $ million, 2021-26
  • Table 8: South Africa generics market volume forecast: %, 2021-26
  • Table 9: South Africa size of population (million), 2017-21
  • Table 10: South Africa gdp (constant 2005 prices, $ billion), 2017-21
  • Table 11: South Africa gdp (current prices, $ billion), 2017-21
  • Table 12: South Africa inflation, 2017-21
  • Table 13: South Africa consumer price index (absolute), 2017-21
  • Table 14: South Africa exchange rate, 2017-21
  • Table 15: Brazil generics market value: $ million, 2016-21
  • Table 16: Brazil generics market volume: %, 2016-21
  • Table 17: Brazil generics market geography segmentation: $ million, 2021
  • Table 18: Brazil generics market value forecast: $ million, 2021-26
  • Table 19: Brazil generics market volume forecast: %, 2021-26
  • Table 20: Brazil size of population (million), 2017-21
  • Table 21: Brazil gdp (constant 2005 prices, $ billion), 2017-21
  • Table 22: Brazil gdp (current prices, $ billion), 2017-21
  • Table 23: Brazil inflation, 2017-21
  • Table 24: Brazil consumer price index (absolute), 2017-21
  • Table 25: Brazil exchange rate, 2017-21
  • Table 26: China generics market value: $ billion, 2016-21
  • Table 27: China generics market volume: %, 2016-21
  • Table 28: China generics market geography segmentation: $ billion, 2021
  • Table 29: China generics market value forecast: $ billion, 2021-26
  • Table 30: China generics market volume forecast: %, 2021-26
  • Table 31: China size of population (million), 2017-21
  • Table 32: China gdp (constant 2005 prices, $ billion), 2017-21
  • Table 33: China gdp (current prices, $ billion), 2017-21
  • Table 34: China inflation, 2017-21
  • Table 35: China consumer price index (absolute), 2017-21
  • Table 36: China exchange rate, 2017-21
  • Table 37: India generics market value: $ billion, 2016-21
  • Table 38: India generics market volume: %, 2016-21
  • Table 39: India generics market geography segmentation: $ billion, 2021
  • Table 40: India generics market value forecast: $ billion, 2021-26
  • Table 41: India generics market volume forecast: %, 2021-26
  • Table 42: India size of population (million), 2017-21
  • Table 43: India gdp (constant 2005 prices, $ billion), 2017-21
  • Table 44: India gdp (current prices, $ billion), 2017-21
  • Table 45: India inflation, 2017-21
  • Table 46: India consumer price index (absolute), 2017-21
  • Table 47: India exchange rate, 2017-21
  • Table 48: Mexico generics market value: $ million, 2016-21
  • Table 49: Mexico generics market volume: %, 2016-21
  • Table 50: Mexico generics market geography segmentation: $ million, 2021
  • Table 51: Mexico generics market value forecast: $ million, 2021-26
  • Table 52: Mexico generics market volume forecast: %, 2021-26
  • Table 53: Mexico size of population (million), 2017-21
  • Table 54: Mexico gdp (constant 2005 prices, $ billion), 2017-21
  • Table 55: Mexico gdp (current prices, $ billion), 2017-21
  • Table 56: Mexico inflation, 2017-21
  • Table 57: Mexico consumer price index (absolute), 2017-21
  • Table 58: Mexico exchange rate, 2017-21
  • Table 59: Aspen Pharmacare Holdings Ltd: key facts
  • Table 60: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
  • Table 61: Aspen Pharmacare Holdings Ltd: Key Employees
  • Table 62: Adcock Ingram Holdings Ltd: key facts
  • Table 63: Adcock Ingram Holdings Ltd: Annual Financial Ratios
  • Table 64: Adcock Ingram Holdings Ltd: Key Employees
  • Table 65: Sanofi SA: key facts
  • Table 66: Sanofi SA: Annual Financial Ratios
  • Table 67: Sanofi SA: Key Employees
  • Table 68: Sanofi SA: Key Employees Continued
  • Table 69: EMS SA: key facts
  • Table 70: EMS SA: Key Employees
  • Table 71: Eurofarma Laboratorios SA: key facts
  • Table 72: Eurofarma Laboratorios SA: Key Employees
  • Table 73: Ache Laboratorios Farmaceuticos SA: key facts
  • Table 74: Ache Laboratorios Farmaceuticos SA: Key Employees
  • Table 75: Teva Pharmaceutical Industries Limited: key facts
  • Table 76: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
  • Table 77: Teva Pharmaceutical Industries Limited: Key Employees
  • Table 78: Viatris Inc.: key facts
  • Table 79: Viatris Inc.: Annual Financial Ratios
  • Table 80: Viatris Inc.: Key Employees

List of Figures

  • Figure 1: Top 5 emerging countries generics industry, revenue ($m), 2017-26
  • Figure 2: Top 5 emerging countries generics industry, revenue ($m), 2017-21
  • Figure 3: Top 5 emerging countries generics industry forecast, revenue ($m), 2021-26
  • Figure 4: South Africa generics market value: $ million, 2016-21
  • Figure 5: South Africa generics market volume: %, 2016-21
  • Figure 6: South Africa generics market geography segmentation: % share, by value, 2021
  • Figure 7: South Africa generics market value forecast: $ million, 2021-26
  • Figure 8: South Africa generics market volume forecast: %, 2021-26
  • Figure 9: Forces driving competition in the generics market in South Africa, 2021
  • Figure 10: Drivers of buyer power in the generics market in South Africa, 2021
  • Figure 11: Drivers of supplier power in the generics market in South Africa, 2021
  • Figure 12: Factors influencing the likelihood of new entrants in the generics market in South Africa, 2021
  • Figure 13: Factors influencing the threat of substitutes in the generics market in South Africa, 2021
  • Figure 14: Drivers of degree of rivalry in the generics market in South Africa, 2021
  • Figure 15: Brazil generics market value: $ million, 2016-21
  • Figure 16: Brazil generics market volume: %, 2016-21
  • Figure 17: Brazil generics market geography segmentation: % share, by value, 2021
  • Figure 18: Brazil generics market value forecast: $ million, 2021-26
  • Figure 19: Brazil generics market volume forecast: %, 2021-26
  • Figure 20: Forces driving competition in the generics market in Brazil, 2021
  • Figure 21: Drivers of buyer power in the generics market in Brazil, 2021
  • Figure 22: Drivers of supplier power in the generics market in Brazil, 2021
  • Figure 23: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2021
  • Figure 24: Factors influencing the threat of substitutes in the generics market in Brazil, 2021
  • Figure 25: Drivers of degree of rivalry in the generics market in Brazil, 2021
  • Figure 26: China generics market value: $ billion, 2016-21
  • Figure 27: China generics market volume: %, 2016-21
  • Figure 28: China generics market geography segmentation: % share, by value, 2021
  • Figure 29: China generics market value forecast: $ billion, 2021-26
  • Figure 30: China generics market volume forecast: %, 2021-26
  • Figure 31: Forces driving competition in the generics market in China, 2021
  • Figure 32: Drivers of buyer power in the generics market in China, 2021
  • Figure 33: Drivers of supplier power in the generics market in China, 2021
  • Figure 34: Factors influencing the likelihood of new entrants in the generics market in China, 2021
  • Figure 35: Factors influencing the threat of substitutes in the generics market in China, 2021
  • Figure 36: Drivers of degree of rivalry in the generics market in China, 2021
  • Figure 37: India generics market value: $ billion, 2016-21
  • Figure 38: India generics market volume: %, 2016-21
  • Figure 39: India generics market geography segmentation: % share, by value, 2021
  • Figure 40: India generics market value forecast: $ billion, 2021-26
  • Figure 41: India generics market volume forecast: %, 2021-26
  • Figure 42: Forces driving competition in the generics market in India, 2021
  • Figure 43: Drivers of buyer power in the generics market in India, 2021
  • Figure 44: Drivers of supplier power in the generics market in India, 2021
  • Figure 45: Factors influencing the likelihood of new entrants in the generics market in India, 2021
  • Figure 46: Factors influencing the threat of substitutes in the generics market in India, 2021
  • Figure 47: Drivers of degree of rivalry in the generics market in India, 2021
  • Figure 48: Mexico generics market value: $ million, 2016-21
  • Figure 49: Mexico generics market volume: %, 2016-21
  • Figure 50: Mexico generics market geography segmentation: % share, by value, 2021
  • Figure 51: Mexico generics market value forecast: $ million, 2021-26
  • Figure 52: Mexico generics market volume forecast: %, 2021-26
  • Figure 53: Forces driving competition in the generics market in Mexico, 2021
  • Figure 54: Drivers of buyer power in the generics market in Mexico, 2021
  • Figure 55: Drivers of supplier power in the generics market in Mexico, 2021
  • Figure 56: Factors influencing the likelihood of new entrants in the generics market in Mexico, 2021
  • Figure 57: Factors influencing the threat of substitutes in the generics market in Mexico, 2021
  • Figure 58: Drivers of degree of rivalry in the generics market in Mexico, 2021
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!